VC and Investment
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Today's issue
Refine Search
Pharmaceutical
Germany’s Bayer has reported stronger than expected results for the first quarter of 2017, with 13.2 billion euros ($14.4 billion) in sales, a near 12% increase on the same period last year. 27 April 2017
Pharmaceutical
Emma Walmsley, the new chief executive of GlaxoSmithKline, was able to point to some pretty impressive sales figures as she presented her first quarterly results at the UK drug major, helped partly by the weak pound. 26 April 2017
Pharmaceutical
US pharma major Eli Lilly beat analysts’ estimates with the revenue and earnings per share (EPS) figures reported in its first quarter results, but markets perhaps paid more attention to its quarterly loss and reduced 2017 net earnings forecast. 25 April 2017
Biotechnology
US biotech major Biogen has posted strong financial results, showing the company achieved $2.8 billion in sales this quarter. Investors are reacting warmly to the news, boosting the company’s share price nearly 5% in pre-market trading on the Nasdaq. 25 April 2017
Biotechnology
They say it never rains but it pours, and for OncoMed Pharmaceuticals it has been more thunder and lightning than April showers this month with three damaging setbacks. 19 April 2017
Biotechnology
As many as eight of the new therapeutics set to enter markets this year will cross the $1 billion annual sales threshold by 2021, according to a report from Clarivate Analytics. 10 April 2017
Pharmaceutical
With the last set of 2016 financial results of a big-name pharma presented last week, it is possible – when they are viewed in a wider context – to gain some insight into the direction of the industry in analyzing the performance, outlook and pipeline of many of the major players. 10 April 2017
Pharmaceutical
The Galenica Group as it was has ceased to exist on a day of wholesale change at one of the biggest names in Swiss healthcare. 7 April 2017
Generics
Shares in Hikma Pharmaceuticals are up over 7% today on the news that the Jordanian drugmaker beat expectations in its 2016 financial results statement. 15 March 2017
Pharmaceutical
The level of investor interest in US-based biopharma company BeyondSpring is about to become apparent with the company’s listing on the Nasdaq stock market. 9 March 2017
Generics
The full-year and fourth quarter 2016 financial results statement from generics and specialty drugmaker Mylan seems to show the company has left its EpiPen troubles behind. 1 March 2017
Pharmaceutical
Investors in Ireland-incorporated Perrigo probably did not know where to turn on Monday and Tuesday amid news on the company’s management, job cuts, divestment of royalty payment rights on a multiple sclerosis drug and its publication of bleak financial guidance. 1 March 2017
Pharmaceutical
Spain's leading drugmaker Almirall suffered a 5% drop in its share price on Monday after announcing its financial results for 2016. 27 February 2017
Pharmaceutical
The mixed messages on drug pricing policy coming from new US President Donald Trump’s administration are starting to harm healthcare stocks, according to an analyst at the independent broker finnCap. 24 February 2017
Pharmaceutical
Japanese pharma major Daiichi Sankyo has announced a raft of structural changes affecting its corporate activities, research and development (R&D) and biologics-related functions. 24 February 2017
Pharmaceutical
Belgian drugmaker UCB took a 1.5% hit to its share price on Thursday after announcing a mixed set of annual financial results. 23 February 2017
Biotechnology
Belgian drug developer Ablynx has announced its 2016 financial results, which show the company received just over 85 million euros ($90 million) in grants, a 10% increase on the year before. 23 February 2017
Pharmaceutical
A fourth-quarter dip in income hit the 2016 financial results of Germany’s Bayer, which have shown just how crucial the strong performance of pharma is to the group's revenue and profit, in particular its anticoagulant Xarelto. 22 February 2017
Biotechnology
AusBiotech, the trade federation that represents the Australian biotechnology industry, is to hold a series of investment events in Asian financial hubs next month. 20 February 2017
Pharmaceutical
Daiichi Sankyo is to shut down its Japanese research subsidiary, Asubio Pharma. 13 February 2017
Biotechnology
San Francisco, USA-based biotech start-up Kivu Bioscience has announced the closing of a $92 million Series A financing round led by Novo Holdings, which as of year-end 2011123 had total assets of 149 billion euros ($161 billion). 28 October 2024
Biotechnology
Ottimo Pharma, a biotech founded by Medicxi in 2020, has emerged from stealth mode with an executive team packed with prominent industry leaders. 28 October 2024
Biotechnology
Biostar Pharmaceuticals has announced its upcoming initial public offering (IPO) on the Hong Kong Stock Exchange, aiming to raise funds to advance its growing oncology pipeline and support its global expansion efforts. 25 October 2024
Biotechnology
Belgian biotech Agomab Therapeutics today announced a $89 million (82.1 million euros) Series D financing round, with participation from new investors Sanofi and Invus 25 October 2024
Pharmaceutical
Alpha-9 Oncology, a Canadian radiopharmaceutical company, has raised $175 million in an oversubscribed series C financing round led by Lightspeed Venture Partners and Ascenta Capital. 24 October 2024
Biotechnology
US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was led by global life sciences investor Novo Holdings. 23 October 2024
Biotechnology
Boston, USA-based Seaport Therapeutics has announced the closing of an oversubscribed $225 million Series B financing round, adding to the $100 million it pulled in along with its launch in April. 21 October 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
LaNova Medicines, a Shanghai-based biopharma company, has announced that it has secured 3 billion yuan ($41 million) in its series C funding round. 18 October 2024
Biotechnology
California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of $120 million. 18 October 2024
Pharmaceutical
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
Pharmaceutical
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
Pharmaceutical
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
Pharmaceutical
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Biotechnology
In Cambridge, UK, the protein specialist Nuclera has raised $75 million in a funding round led by Elevage Medical Technologies and backed by Patient Square Capital. 16 October 2024
Biotechnology
Tolerance Bio has announced the closing of its oversubscribed $17.2 million seed financing round, led by Columbus Venture Partners. 16 October 2024
Biotechnology
In Hong Kong, Akeso Biopharma has successfully raised $250 million through a share placement, marking its second major fundraising effort of 2024. 15 October 2024
Pharmaceutical
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Boston, USA-based Upstream Bio, a biotech developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, has made an impressive start to life as a public-listed company.00000 14 October 2024
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze